Cite
Circulating tumor DNA (ctDNA) mutation and epigenomic patterns in early-stage lung cancer patients and its utility in identifying patients at high risk for early recurrence
MLA
Se-Hoon Lee, et al. “Circulating Tumor DNA (CtDNA) Mutation and Epigenomic Patterns in Early-Stage Lung Cancer Patients and Its Utility in Identifying Patients at High Risk for Early Recurrence.” Journal of Clinical Oncology, vol. 37, May 2019, p. e14557. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........8713b3d620147dc739cc5c0683175247&authtype=sso&custid=ns315887.
APA
Se-Hoon Lee, AmirAli Talasaz, Jung Hee Lee, Ariel Jaimovich, Il-Jin Kim, Matthew Shultz, Jinseon Lee, Jhingook Kim, Justin I. Odegaard, Jong Ho Cho, & Hong Kwan Kim. (2019). Circulating tumor DNA (ctDNA) mutation and epigenomic patterns in early-stage lung cancer patients and its utility in identifying patients at high risk for early recurrence. Journal of Clinical Oncology, 37, e14557.
Chicago
Se-Hoon Lee, AmirAli Talasaz, Jung Hee Lee, Ariel Jaimovich, Il-Jin Kim, Matthew Shultz, Jinseon Lee, et al. 2019. “Circulating Tumor DNA (CtDNA) Mutation and Epigenomic Patterns in Early-Stage Lung Cancer Patients and Its Utility in Identifying Patients at High Risk for Early Recurrence.” Journal of Clinical Oncology 37 (May): e14557. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........8713b3d620147dc739cc5c0683175247&authtype=sso&custid=ns315887.